Business Wire

XPRIZE Identifies 10 Future Breakthroughs Required to Protect Our Forests

Del

Today, on the United Nations’ International Day of Forests, XPRIZE is releasing the Future of Forests Impact Roadmap, created in partnership with Kimberly-Clark Corporation. The digital report and its interactive website, based on future foresight techniques, illustrate the breakthroughs required for a healthier forest ecosystem, which might be the basis of future XPRIZE competitions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190321005409/en/

Across the world, forests provide food security and shelter, protect biodiversity and house indigenous populations. While forests cover more than 30 percent of the Earth’s surface, more than 32 million acres of forests are lost due to human activity every year, with research showing that continued mass deforestation and degradation is accelerating climate change.

XPRIZE designs and operates global competitions to incentivize the development of technological breakthroughs that accelerate humanity toward a better future. Part of its prize design efforts include Impact Roadmaps – detailed reports that analyze complex and overlapping social, technological, economic, environmental, and policy issues, to identify the most effective solutions within a given domain. XPRIZE Impact Roadmaps are created through extensive secondary research, expert interviews, collaborative workshops with leading organizations and partners, along with crowdsourced feedback and activities through online communities.

“At XPRIZE, we believe both competition and collaboration are key to unlocking solutions to some of the greatest challenges of our time,” said Zenia Tata, chief impact officer of XPRIZE. “The threats to our forests are catastrophic, but the innovative breakthroughs and passionate community behind the Future of Forests Impact Roadmap make us hopeful that together we can spark something truly revolutionary to help restore and revive our environment.”

For the Future of Forests Impact Roadmap, XPRIZE conducted a literature review on existing forest research, interviewed dozens of experts in the field, and engaged stakeholders from more than 90 organizations, including universities, non-profits, government agencies and private companies to gather input and assess its findings.

“Raising awareness of the current state of our forests is just the first step in bringing about radical change,” said Francois Dufresne, president of the Forests Stewardship Council. “We are passionate about helping empower people, particularly Indigenous people, make everyday choices to help support our forests, and participating in the Future of Forests Impact Roadmap gave us a great, new way to catalyze a community of innovators to help protect our environment.”

“Innovative, sustainable management of the world's forest resources has unparalleled economic, environmental and social benefits,” said Alexander Buck, executive director of International Union of Forest Research Organizations. “It was an honor being a part of the Future of Forests Impact Roadmap, and we’re confident that through communication, collaboration, visibility and outreach, these breakthroughs can unlock new science-based innovations for forest management.”

The Future of Forests Impact Roadmap identifies the following breakthroughs for achieving a better future for forests and humankind:

  1. Super-Wood – A sustainably-produced alternative for wood that shifts the reliance on virgin wood from natural forests and plantations to another material that is sustainably produced and possesses the same strengths and qualities of natural wood.
  2. Global Transparency – A system that will provide traceability and transparency of forest-related activities, leading to better accountability.
  3. Super-Farming – Alternative, and highly-efficient farming methods, that take land-use pressure off forests by providing substantially larger crop yields, with lower energy expenditure and fewer waste byproducts.
  4. X-Meat – Alternative, highly-efficient methods for meat production, that eliminate most of the waste and pollution provided by cattle ranching and minimize energy and feed expenditures.
  5. Forest Regeneration – Cost-effective methods that could be widely utilized to restore existing forests and establish new ones.
  6. Value of Forests – Techniques, methods and platforms that help assess the ecological value (ecosystem service) of forests at high resolution.
  7. Stopping Wildfires – Highly-efficient wildfire prevention and mitigation techniques that would provide better wildfire prevention, mitigation and management.
  8. Invasive Species – A decentralized system that detects and aids in the elimination of harmful and invasive species.
  9. Super-Charcoal – Scalable and highly-efficient methods and technologies for converting wood into charcoal.
  10. Carbon Sequestration – Strengthening the role of forests in carbon sequestration and storage, thereby slowing down climate change and mitigating its effects.

“As an organization, we have an ambitious set of sustainability goals that will have a lasting impact on the people and communities we serve around the world,” said Lisa Morden, Vice President, Safety and Sustainability, Kimberly-Clark Corporation. “Partnering with XPRIZE to create the Future of Forests Impact Roadmap embodies these ambitions by giving us another avenue to helping people understand the importance of our environment and revealing breakthroughs that will help us transform our planet.”

The Future of Forests Impact Roadmap follows XPRIZE’s first Impact Roadmap, the Future of Housing Impact Roadmap, created in partnership with Lowe’s. To learn more or get involved with the Future of Forests Impact Roadmap, visit impactmaps.xprize.org .

About XPRIZE

XPRIZE, a 501(c)(3) nonprofit, is the global leader in designing and implementing innovative competition models to solve the world’s grandest challenges. Active competitions include the Lunar XPRIZE, the $20M NRG COSIA Carbon XPRIZE, the $15M Global Learning XPRIZE, the $10M ANA Avatar XPRIZE, the $7M Shell Ocean Discovery XPRIZE, and the $5M IBM Watson AI XPRIZE. For more information, visit xprize.org.

About Kimberly-Clark

Kimberly-Clark (NYSE: KMB) and its trusted brands are an indispensable part of life for people in more than 175 countries. Fueled by ingenuity, creativity, and an understanding of people's most essential needs, we create products that help individuals experience more of what's important to them. Our portfolio of brands, including Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Neve, Plenitud, Viva and WypAll, hold the No. 1 or No. 2 share position in 80 countries. We use sustainable practices that support a healthy planet, build stronger communities, and ensure our business thrives for decades to come. To keep up with the latest news and to learn more about the company's 147-year history of innovation, visit kimberly-clark.com or follow us on Facebook or Twitter.

Contact information

Eric Desatnik
XPRIZE Communications
prcontact@xprize.org

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

IDEMIA Provides NOS with eSIM Management Solutions18.4.2019 10:49:00 CESTPressemelding

At the occasion of the launch of the first ever eSIM (embedded SIM) service on the Portuguese market, NOS today introduces with IDEMIA an eSIM subscription management commercial service for the consumer market, based on a physical voucher approach and future evolution towards a digital voucher. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190418005321/en/ (Photo: IDEMIA) As a major actor in the telecom field, IDEMIA is at the forefront of the digital revolution and is committed to bringing protected and convenient experiences to mobile operator customers. IDEMIA will be providing NOS its eSIM management solutions that will provide instant digital connectivity that allows users to connect any electronic device straight out-of-the-box and link multiple devices to the same mobile subscription. eSIM offers a streamlined user experience when it comes to managing cellular connectivity for Enterprises. According to ABI Research,

AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines for AqVida’s Cancer-fighting Paclitaxel Injectable Finished Dosage Formulation18.4.2019 10:00:00 CESTPressemelding

Phyton Biotech, a German/North American Plant Cell Fermentation (PCF®) technology company, and AqVida, a German oncology Finished Dosage Formulation (FDF) manufacturer, are pleased to announce today that they have received European approval from the EDQM (European Directorate of Quality Medicines) for AqVida’s paclitaxel injectable FDF. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190418005161/en/ Phyton Biotech is the world’s leading manufacturer of paclitaxel active pharmaceutical ingredient (API), utilizing its prorprietary PCF® technology process. Under the strategic partnership with AqVida, Phyton Biotech will be the exclusive supplier of paclitaxel API for AqVida’s Taxol generic formulation, which is produced in AqVida’s new state-of-the-art injectable manufacturing facility located in Dassow, Germany. AqVida’s ultramodern robotic manufacturing line, designed for filling cytotoxic injectables, will be utilized to pro

Racketeering Lawsuit Filed by Boies Schiller Flexner LLP Alleges Czech Oligarch Defrauds US Hedge Fund and Former Partner Out of Over $1 Billion18.4.2019 07:41:00 CESTPressemelding

New York hedge fund, Kingstown Capital Management L.P, and other plaintiffs filed a lawsuit on 10 April 2019 in the Southern District of New York against Radovan Vitek, a Czech real estate mogul with business interests throughout Europe, whose fortune Forbes magazine estimates at $3.5 billion. Represented by litigation powerhouse Boies Schiller Flexner LLP, the hedge fund Kingstown Capital Management L.P and Czech investment firm Investhold Ltd allege that Vitek ran an elaborate criminal enterprise that defrauded the plaintiffs out of more than US $1 billion. According to the complaint, Berlin’s largest commercial real estate landlord, Vitek engaged in racketeering activity including wire fraud, mail fraud, money laundering, and other crimes and amassed his wealth at the expense of the plaintiffs, according to the complaint. His commercial interests span multiple jurisdictions including the Czech Republic, Switzerland, Luxembourg, Germany, Croatia and UK. The complaint alleges that Vit

MHI Thermal Systems Develops Demonstration Unit of the World’s First Small-Capacity Residential Air-Conditioner Adopting the Low-GWP R454C Refrigerant18.4.2019 07:21:00 CESTPressemelding

Premiering for the first time in the world, Mitsubishi Heavy Industries Thermal Systems, Ltd., a Group company of Mitsubishi Heavy Industries, Ltd. (MHI) (TOKYO: 7011), is adopting R454C, a refrigerant with an extremely low global warming potential (GWP), in a 1-horsepower (HP) class residential air-conditioner. The conventional shortcomings of the R454C,for example; inferior heat exchanger performance attributable to it being a mixed refrigerant have been overcome through the use of proprietary technology that optimize the heat exchanger’s flow volume and other measures. The company has already developed a demonstration unit of the residential air-conditioner featuring R454C and preparations are underway towards mass production with an eye on an initial launch into the European market, where environmental regulations are particularly stringent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190418005241/en/ Residential type

Hologic Receives European CE Mark for ThinPrep® Genesis Processor, an Automated Cytology Slide and Molecular Sample System18.4.2019 07:00:00 CESTPressemelding

Hologic, Inc. (Nasdaq: HOLX) announced today that the ThinPrep® Genesis processor for cytology slide and molecular test preparation has received a CE IVD mark in Europe. The system features increased automation capabilities, together with ergonomic and chain of custody benefits, compared to older instruments. Most importantly, the instrument will prepare slides for cytology as well as aliquot samples for molecular testing, reducing manual sample handling. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190418005130/en/ ThinPrep Genesis processor (Photo: Business Wire) The Genesis processor is the latest extension of the ThinPrep portfolio, which revolutionized and increased the accuracy of cervical cancer screening with the first liquid-based Pap test in 1996. Hologic launched an updated ThinPrep® 2000 processor in 2017 and received FDA approval in 2018 for the ThinPrep® Integrated Imager, which guides cytotechnologists to ar

Ipsen Completes Acquisition of Clementia Pharmaceuticals18.4.2019 05:00:00 CESTPressemelding

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) and Clementia Pharmaceuticals (NASDAQ: CMTA) today announced the closing of Ipsen’s acquisition of Clementia following approval of the arrangement by Clementia shareholders and the Quebec Superior Court. Pursuant to the arrangement, Clementia shareholders will receive US$25.00 per share in cash upfront and one contingent value right (CVR) per share entitling them to receive US$6.00 per CVR upon the U.S. Food and Drug Administration's (FDA) acceptance of the regulatory filing for palovarotene for the treatment of multiple osteochondromas (MO). Clementia’s key late-stage clinical asset palovarotene is an investigational retinoic acid receptor gamma (RARγ) selective agonist, for the treatment of two rare bone disorders, fibrodysplasia ossificans progressiva (FOP) and multiple osteochondromas (MO), and other diseases. The palovarotene regulatory submission for the prevention of heterotopic ossification (HO) in patients with FOP in the U.S.